RudaCure Inc. attends the Global Bio Expo BIO USA 2024
RudaCure Inc. (hereinafter "RudaCure"), a company specializing in the desarrollo of tratamientos for ocular diseases and dolor crónico, asistió the 'BIO International Convention 2024' (hereinafter "BIO USA") celebrado en San Diego, USA from June 3 to June 6. BIO USA is the world's largest biotecnología industria expo, offering a comprehensive view of the latest trends and innovador technologies in el mercado global de bio industria.
At this expo, RudaCure showcased its latest I+D logros and technological capabilities while exploring opportunities to build asociación globals and colaboracións. En particular, RudaCure's key products—tratamiento de la enfermedad de ojo seco (RCI001) and úlcera corneal tratamiento (RCI001U)—drew significant attention from attendees.
Throughout the event, RudaCure realizó business meetings with a variety of global pharmaceutical and biotech empresas, engaging in discussions on transferencia de tecnología and joint I+D. Through these interactions, RudaCure aims to strengthen its position in the mercado global and enhance its internacional competitiveness.
RudaCure planea grow into a global bioempresa farmacéutica that contributes to improving human health and quality of life through continuous I+D and innovación. This participación in BIO USA se espera que further solidify RudaCure's standing in el mercado global de bio mercado and mark an important turning point for la empresa's future crecimiento.